Clin2
NCT07157020Possibly a fitNot yet recruiting

Preventing and spotting brain bleeding in premature babies

Intraventricular Hemorrhage of Prematurity

Part of Brain & nervous system, Women’s health & pregnancy clinical trials.

This study looks at ways to prevent, find early, and manage bleeding in the brain and the fluid buildup that can follow in premature babies. If your baby had such bleeding and fluid buildup, the study may offer close monitoring and care to help improve outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
Up to 4 weeks
Study type
Interventional

Who can take part

  • Your baby was born between 23 weeks and 36 weeks plus 6 days of pregnancy.
  • Your baby has been diagnosed with bleeding in the brain (intraventricular hemorrhage).
  • After the bleeding, your baby developed extra fluid in the brain (hydrocephalus).
  • Your baby has not yet had any procedure to drain fluid from the brain or spine.
  • The extra fluid is not caused by an infection, a birth defect, a brain tumor, or other factors like low vitamin K or bleeding problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07198360Not yet recruiting
Brain bleeding in premature babies

This study looks at premature babies who are born very early and weigh very little, to understand bleeding in the brain (called intraventricular hemorrhage). If your baby is eligible, the research may help doctors learn more about this condition and how to manage it.

NCT06797219Recruiting
Light therapy device study for newborns with severe brain bleeding

This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.

Newark, New Jersey
NCT05617833Recruiting· Phase 1
Test EPO and melatonin for brain bleeding in very preterm babies

This Phase 1 trial studies whether giving erythropoietin (EPO) and melatonin is safe in very preterm infants who have bleeding in the brain (intraventricular hemorrhage) or significant nearby brain injury. It aims to see if these medicines can be given safely during the early days after birth.

St. Petersburg, Florida
NCT07733778Not yet recruiting
Gentle washing of brain fluid spaces for newborn bleeding

This trial tests a procedure called neuroendoscopic lavage, which uses a small camera and fluid to gently wash out blood from the fluid spaces in a newborn's brain after a severe bleeding. It aims to reduce pressure and help prevent further damage.

NCT06572917Not yet recruiting· Phase 2
Preventing bleeding in the brain of very premature babies

This study tests if giving a single dose of a medicine called indomethacin to very premature babies can help prevent bleeding in the brain. The medicine is given soon after birth to babies born before 26 weeks of pregnancy or weighing less than 750 grams.

Roseville, California
NCT05708105Recruiting
Testing ultrasound and near-infrared light to predict brain bleeding

This study looks at using two noninvasive tools on very preterm newborns to better predict whether an intraventricular hemorrhage (bleeding in the brain’s fluid spaces) may happen. If successful, it could help doctors spot risk earlier and monitor or treat babies sooner.

Calgary, Alberta

Hear when a new Intraventricular Hemorrhage of Prematurity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.